pipette
ESEspañol

Bioactivity foundation model for hit identification and hit-to-lead optimization from sequence data

H. Y. Koh, H. J. W. Koh, Y. Zheng, V. Naranbhai, D. F. Schmidt, J. Barthelemy, Y.-J. Chen, A. T. N. Nguyen, S. Pan, L. T. May, G. I. Webb

PreprintReal-world use

In the authors' words

Learning from large-scale bioactivity archives is complicated by heterogeneous assay readouts and differences in data reliability. Here we show that a model that predicts probability distributions over binding affinities from sequence data opens model training to vast and diverse troves of heterogeneous bioactivity data. We develop PSICHIC+, a bioactivity foundation model trained on approximately 82 million protein-ligand records using a distributional objective that preserves quantitative resolution while incorporating variation in data reliability. Given a protein sequence and ligand SMILES, PSICHIC+ predicts binding affinity in milliseconds. In zero-shot virtual-screening benchmarks without target-specific training data, it improves enrichment over regression- and classification-based approaches and performs competitively with leading structure-based methods. In lab-in-the-loop campaigns, distribution-guided acquisition improves recovery of high-activity compounds under fixed screening budgets. Combining PSICHIC+ with Boltz-2 improves hit-to-lead affinity prediction over Boltz-2 alone, with mean correlation approaching that of FEP+ on the evaluated benchmarks, without requiring high-resolution protein structures. These results support distributional learning as a scalable approach to using heterogeneous bioactivity data for hit identification and hit-to-lead optimization.

Main resultThe abstract does not state a limitation.

Appeared: Sunday, November 1. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.26.762100